|
|
||||||||
Correspondence to:
Geesje M. Dallinga-Thie, To whom correspondence should be addressed., g.m.dallingathie{at}digd.azu.nl (E-mail)
Linkage and association between the apolipoprotein (apo) A-I/C-III/A-IV gene region on chromosome 11 and familial combined hyperlipidemia (FCHL) has been observed previously. Using sequence analysis two new allelic variants were identified, C317 -T in intron 2 of the apoA-I gene and C1100-T in exon 3 of the apoC-III gene. These variants were studied in 30 FCHL probands, 159 hyperlipidemic relatives, 327 normolipidemic relatives, and 218 spouses. The allele frequencies of both variants were significantly different in probands and spouses (P < 0.002 and P < 0.001, respectively), with increased frequency of the minor alleles in the probands. The minor genotypes (TT) were associated with elevated plasma triglyceride and apoC-III. Both variants were in strong, although not complete, linkage disequilibrium with each other and with the MspI site in the promoter region of the apoA-I gene and the SstI site in the 3' untranslated region of exon 4 of the apoC-III gene. Haplotypes based on these four variants were constructed and the distributions of haplotype combinations were significantly different (P < 0.0001). Two distinct haplotypes predisposing to FCHL were found: 2-2-1-2 and 1-2-2-2 (MspI, C317 -T; SstI, C1100-T). The haplotype combinations carrying one of these high risk alleles are associated with elevated lipid levels in probands and in spouses.
While these effects can be attributed to the presence of the M2 and S2 minor alleles, these results suggest that the importance of specific allelic haplotypes may be greater than single genotypic effects. Groenendijk, M., R. M. Cantor, T. W. A. De Bruin, and G. M. Dallinga-Thie. New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia. J. Lipid Res. 2001. 42: 188;194.
Supplementary key words:
haplotypes, polymorphism, apolipoproteins
Copyright © 2001 by Lipid Research, Inc.
Original Article
New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia
Martine Groenendijka,
Rita M. Cantorb,
Tjerk W. A. De Bruinc, and
Geesje M. Dallinga-Thiea
a Department of Internal Medicine, University Medical Center Utrecht, 3508 GA Utrecht, The Netherlands
b Departments of Pediatrics and Human Genetics, University of California at Los Angeles, Los Angeles, CA 90095
c Departments of Medicine and Endocrinology, Academic Hospital, 6202 AZ Maastricht, The Netherlands
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
J. Rhee, H. Ge, W. Yang, M. Fan, C. Handschin, M. Cooper, J. Lin, C. Li, and B. M. Spiegelman Partnership of PGC-1{alpha} and HNF4{alpha} in the Regulation of Lipoprotein Metabolism J. Biol. Chem., May 26, 2006; 281(21): 14683 - 14690. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Cardona, F J Tinahones, E Collantes, A Escudero, E Garcia-Fuentes, and F J Soriguer Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout Ann Rheum Dis, January 1, 2005; 64(1): 85 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Aouizerat, M. Kulkarni, D. Heilbron, D. Drown, S. Raskin, C. R. Pullinger, M. J. Malloy, and J. P. Kane Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids J. Lipid Res., June 1, 2003; 44(6): 1167 - 1173. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |